홈/MCK

Public research page

Market data comes from the live feed. The company research below uses verified public sources, but it is not a real-time personalized AI conclusion.

Analyze MCK in workspace
MCKNYSE/health care

McKesson Corporation

$812.28Up+6,32 (+0,78%)
Research reviewed: 2026년 7월 12일 AM 12:00 UTC
Research overview3-month price contextInvestment thesisKey catalystsLatest earnings researchRecent newsData and research sources

Research overview

McKesson Corporation operates in Health Care Distributors within the health care sector. This profile tracks its company-specific earnings drivers, valuation conditions, and primary-source risks.

Eröffnung
812,87
Hoch
822,38
Tief
806,24
Marktkapitalisierung
95,1 Mrd.
KGV
21.18
52-Wochen-Hoch
--
Dividende
0.410%
Quartalsdividende
--

3-month price context

최근 3개월 추세를 통해 전체 리서치 워크스페이스로 가기 전 단기 구조를 빠르게 파악할 수 있습니다.

Investment thesis

Base case
Growth in complex medicines can increase distribution, provider-services and data demand. The base case remains conditional on customer concentration staying manageable.
Bull case
Growth in complex medicines can increase distribution, provider-services and data demand. The US Oncology Network and related services can deepen relationships with community practices and manufacturers. Strong cash conversion can fund repurchases and targeted investment in higher-growth health platforms.
Bear case
Large pharmacy and manufacturer relationships can create contract-renewal and pricing leverage risk. Reimbursement, pricing and distribution reforms can alter volumes, working capital and service economics. Controlled-substance obligations and healthcare compliance failures can create litigation and remediation costs.
Thesis invalidation
Reassess the thesis if large pharmacy and manufacturer relationships can create contract-renewal and pricing leverage risk.

Key catalysts

  • Specialty distribution

    Growth in complex medicines can increase distribution, provider-services and data demand.

  • Oncology ecosystem

    The US Oncology Network and related services can deepen relationships with community practices and manufacturers.

  • Capital allocation

    Strong cash conversion can fund repurchases and targeted investment in higher-growth health platforms.

Principal risks

  • Customer concentration

    Large pharmacy and manufacturer relationships can create contract-renewal and pricing leverage risk.

  • Drug-policy change

    Reimbursement, pricing and distribution reforms can alter volumes, working capital and service economics.

  • Legal and compliance

    Controlled-substance obligations and healthcare compliance failures can create litigation and remediation costs.

Latest earnings research

FY2026 Q4

McKesson's fiscal fourth-quarter 2026 update reflected resilient pharmaceutical distribution, oncology-platform growth and continued portfolio focus, supported by cash generation and disciplined capital allocation.

Valuation interpretation

  • Distribution scale supports durable cash flow, while oncology and specialty services determine the mix-improvement opportunity.
  • Thin distribution margins require valuation discipline around working capital, customer concentration and policy change.

Peer research

ABBVJNJLLY

Recent news

Zacks · vor 9 Stunden

5 Medical Supply Stocks to Buy Amid Strong Industry Tailwinds

Simply Wall St. · vorgestern

McKesson (MCK) Falls After CEO Share Sale, Is The 14% Discount Enough?

Simply Wall St. · vor 3 Tagen

Can McKesson (MCK) Stay Cheap After A 338% Five Year Run?

Simply Wall St. · vor 3 Tagen

McKesson (MCK) CEO Sells Shares As Company Names A New Strategy Chief

StockStory · vor 4 Tagen

McKesson (MCK) Stock Trades Down, Here Is Why

Zacks · vor 4 Tagen

Should You Retain CAH Stock After Removal From Several Russell Indices?

Data and research sources

Research updated: 2026년 7월 12일 AM 12:00 UTC
3 verified sources
McKesson Reports Fiscal 2026 Fourth-Quarter ResultsMcKesson Corporation · earningsVerified

Fetched: 2026. 7. 12. AM 12시 0분 0초 UTC

Published: 2026. 5. 7. AM 12:00:00

Open original source
McKesson Corporation Investor RelationsMcKesson Corporation · companyVerified

Fetched: 2026. 7. 12. AM 12시 0분 0초 UTC

Open original source
McKesson SEC filings and company factsU.S. Securities and Exchange Commission · filingVerified

Fetched: 2026. 7. 12. AM 12시 0분 0초 UTC

Published: 2026. 5. 7. AM 12:00:00

Open original source

Continue in the research workspace

Keep MCK in context, run a multi-agent analysis, and monitor thesis changes.

Analyze MCK free

전체 리서치 시스템 살펴보기

각 단계는 고유한 역할을 수행하고 다음 단계가 확인할 수 있는 결과를 남깁니다.

리서치 방법론시장 보고서 읽기종목 둘러보기

Continue researching this stock

시장 분석가

시장 분석가는 핵심 리서치 안에서 관찰 단계에 집중해 다음 판단의 전제를 정리하는 역할입니다.

기본면 분석가

기본면 분석가는 핵심 리서치 안에서 관찰 단계에 집중해 다음 판단의 전제를 정리하는 역할입니다.

뉴스 분석가

뉴스 분석가는 핵심 리서치 안에서 관찰 단계에 집중해 다음 판단의 전제를 정리하는 역할입니다.

리스크 매니저

리스크 매니저는 리스크와 모니터링 안에서 모니터링 단계에 집중해 다음 판단의 전제를 정리하는 역할입니다.